Status
Conditions
Treatments
About
The goal of this trial is to assess the effect on the quality of life (QoL) of recommending a fat-free diet versus a balanced WHO diet in symptomatic patients with gallstones and in patients undergoing cholecystectomy for gallstone disease. The main question it aims to answer is:
• Is balanced WHO diet as good as low-fat diet in terms of patient reported outcomes when gallstone disease is managed non-operatively (RADIGAL-1) or cholecystectomy is performed (RADIGAL-2)?
A validated QoL questionnaire (Gastrointestinal Quality of Life Index - GIQLI) will be administered both at baseline and during follow-up. Analysis of covariance with ordinary least squares estimation will be applied to estimate between-group differences in GIQLI scores at 3 months (primary endpoint). Patient adherence and the disease-related symptoms occurrence or hospitalizations will also be appraised (secondary endpoint).
Participants presenting with biliary colic or acute cholecystitis (RADIGAL-1) or undergoing cholecystectomy for gallstones (RADIGAL-2) will:
This trial examines the impact of diet on adverse events in gallstone disease, representing the first randomized study to focus on this aspect.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria (RADIGAL1):
Exclusion Criteria (RADIGAL1):
Inclusion Criteria (RADIGAL2):
Exclusion Criteria (RADIGAL2):
Primary purpose
Allocation
Interventional model
Masking
242 participants in 4 patient groups
Loading...
Central trial contact
Konstantinos Lasithiotakis, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal